---
title: 'VP, Regulatory Promotion and Advertising at Amylyx Pharmaceuticals'
canonical: 'https://feeny.ai/job/vp-regulatory-promotion-and-advertising-amylyx-pharmaceuticals-cambridge-esz1zfwcwja5'
type: 'job'
last_seen: '2026-09-08'
---

# VP, Regulatory Promotion and Advertising at Amylyx Pharmaceuticals

- **Company:** Amylyx Pharmaceuticals
- **Location:** Cambridge, MA
- **Compensation:** $314k–$353k
- **Posted:** 2026-08-14
- **Last confirmed live:** 2026-09-08
- **Apply:** https://job-boards.greenhouse.io/amylyx/jobs/6143451004

## Job description

Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS).

Our mission is powered by our people. Our core values – be audacious, be curious, be authentic, be engaged, and be accountable – creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine’s toughest problems, we encourage you to read the opportunity below and apply.

The Opportunity

Amylyx Pharmaceuticals is seeking a Vice President, Regulatory Affairs – U.S. Advertising & Promotion (Ad/Promo) which serves as the strategic regulatory leader responsible for providing expert guidance on U.S. advertising, promotion, scientific exchange, and external communications supporting Amylyx’s commercial and development-stage products. This individual partners closely with Commercial, Medical Affairs, Clinical Development, Legal, Compliance, Corporate Communications, and Executive Leadership to enable compliant commercialization strategies while effectively managing regulatory risk.

The Vice President will establish and lead the Company’s U.S. Advertising & Promotion regulatory function, providing strategic oversight across launch planning, promotional review, disease awareness communications, digital initiatives, scientific exchange, patient engagement, payer communications, and future pipeline assets. This individual will represent Amylyx with FDA’s Office of Prescription Drug Promotion (OPDP) and play a critical leadership role supporting the successful launch of avexitide and future commercial products.

We anticipate hiring the VP, Regulatory Promotion and Advertising in September 2026

## Responsibilities

- Provide executive leadership for the U.S. Advertising & Promotion Regulatory Affairs function across all commercial and late-stage development programs.
- Serve as the Company’s primary regulatory expert on FDA advertising and promotion requirements, OPDP guidance, enforcement trends, and evolving regulatory policy.
- Partner with Commercial leadership to develop compliant promotional strategies supporting successful product launches and lifecycle management.
- Lead Regulatory representation on Promotional Review Committees (PRC/MLR), ensuring promotional materials appropriately balance business objectives with regulatory compliance.
- Provide strategic regulatory guidance for:
- Consumer and healthcare professional promotional materials
- Disease awareness campaigns
- Scientific exchange
- Digital and social media initiatives
- Corporate communications
- Investor communications involving product information
- Patient education and advocacy materials
- Payer communications
- Serve as the primary liaison with FDA OPDP, including advisory comment submissions, voluntary submissions, enforcement responses, and other regulatory interactions.
- Collaborate cross-functionally with Regulatory Strategy, Medical Affairs, Clinical Development, Legal, Compliance, Commercial Operations, Market Access, Corporate Communications, and Patient Advocacy.
- Develop regulatory strategies that enable innovative communication approaches while maintaining compliance with FDA regulations and company policies.
- Build scalable Ad/Promo processes, governance models, and operating procedures to support organizational growth.
- Provide strategic risk assessments and recommendations to senior leadership regarding promotional initiatives.
- Monitor evolving FDA guidance, enforcement actions, and industry trends and proactively educate internal stakeholders.
- Develop and mentor a high-performing Advertising & Promotion regulatory organization as the commercial organization expands.
- Support due diligence, business development activities, and pipeline planning from an Advertising & Promotion regulatory perspective.
- Foster a culture of collaboration, accountability, continuous improvement, and regulatory excellence.

Required Qualifications

- Bachelor’s degree with 12+ years, Master’s degree with 10+ years, or PhD with 8+ years of relevant experience in US Advertising and Promotion within the biotechnology or pharmaceutical industry.
- Deep expertise in FDA regulations, guidance, enforcement trends, and industry practices governing prescription drug advertising and promotion, including extensive experience wirth FDA’s Office of Prescription Drug Promotion.
- Demonstrated experience providing strategic regulatory leadership for commercial and launch-stage products, including promotional review, labeling implications, disease awareness, scientific exchange, digital/social media, payer communications, and other external communications.
- Expert knowledge of FDA, ICH, EMA, GCP, eCTD, and global regulatory submission requirements.
- Experience establishing or evolving Ad/Promo governance, processes, standards, and operation models within a growing organization.
- Demonstrated experience leading cross-functional teams and influencing senior stakeholders without direct authority.
- Proven ability to manage multiple high-priority programs simultaneously in a fast-paced development environment.
- Strong project leadership, organizational, and communication skills.
- Experience managing external medical writing vendors and outsourced writing activities.
- Advanced proficiency with Microsoft Office, Adobe Acrobat, document management systems, SharePoint, and structured content management platforms.
- Ability to interpret complex clinical data and translate scientific findings into clear, concise, and scientifically rigorous regulatory documents.
- Experience supporting multiple regulatory submissions, including INDs, NDAs, BLAs, or equivalent global filings.

Work Location and Conditions

- At Amylyx, we proudly support remote work opportunities within the United States. However, due to business considerations related to health insurance coverage and state tax regulations, we are unable to hire employees who reside and/or work in certain states. Currently, we are not considering applicants from Alaska, Arizona, Hawaii, Michigan and Tennessee.
- You will be expected to travel to our corporate location in Cambridge, MA several times a year and attend other company-related events as necessary and requested.
- You must have access to work in setting which enables meeting all requirements of the role (including privacy, reliable internet access, phone, ability to video conference, etc.) at your remote location.

## Compensation

The pay range posted below represents our good faith estimate of compensation for this role, based on market data and internal benchmarks. The final offer may vary depending on a candidate’s experience, skills, and qualifications, as well as considerations of internal equity.

Estimated Pay Range $314,000—$353,000 USD

To stay connected with us, follow Amylyx Pharmaceuticals on [LinkedIn](https://www.linkedin.com/company/amylyx).

To return to our website please [click here](https://www.amylyx.com/).

Amylyx Pharmaceuticals is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, or any other characteristic protected by applicable federal, state, or local laws and ordinances. Amylyx’s management team is dedicated to this policy with respect to recruitment, hiring, placement, promotion, transfer, training, compensation, benefits, employee activities, access to facilities and programs, and general treatment during employment. Accommodations are available for candidates who require them in our selection process. If you need an accommodation, please let your Amylyx Talent Acquisition contact know.

It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.

## About Amylyx Pharmaceuticals

## Company Overview
- **One-liner**: Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel therapies for serious diseases with high unmet needs, including neurodegenerative and rare diseases.
- **Entity Type**: Public (NASDAQ: AMLX)
- **Headquarters**: Cambridge, Massachusetts, United States
- **Founded**: 2013
- **Founders**: Josh Cohen and Justin Klee

## Core Business
- Primary industry/industries: Biotechnology / Pharmaceuticals
- Target customers: Patients, healthcare providers, and payers (B2B/B2C); primarily focused on rare and neurodegenerative diseases
- Mission or purpose statement: To develop novel therapies for high unmet needs with urgency, rigorous science, and unwavering commitment to the communities they serve.

## Products & Services
- **AMX0035 (RELYVRIO®/ALBRIOZA)**: An investigational combination therapy for Wolfram syndrome and previously approved for ALS (voluntarily withdrawn after Phase 3 PHOENIX trial did not meet primary endpoint). Still being studied in Wolfram syndrome.
- **Avexitide**: A Phase 3-ready GLP-1 receptor antagonist with FDA Breakthrough Therapy designation for post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism (HI). Dosing in Phase 3 LUCIDITY trial.
- **AMX0114**: An investigational therapy for ALS, currently in Phase 1 LUMINA clinical trial, with FDA Fast Track designation.
- **AMX0318**: A long-acting GLP-1 receptor antagonist in IND-enabling studies for PBH and other rare diseases, developed in collaboration with Gubra A/S.

## Market Standing
- **Valuation/Market Cap**: Not publicly available from provided sources (public company; market cap fluctuates)
- **Key Metric**: Completed IPO on NASDAQ in April 2025 (ticker: AMLX); annual revenue not disclosed (clinical-stage, no approved products currently marketed)
- **Notable Investors/Partners**: Gubra A/S (research collaboration), Dr. Rudy Tanzi (Founding Chair of Scientific Advisory Board)
- **Growth Signals**: Expanded pipeline with avexitide acquisition (July 2024); multiple FDA designations (Fast Track, Orphan Drug); first patients dosed in Phase 1 LUMINA (ALS) and Phase 3 LUCIDITY (PBH); ongoing IND-enabling studies for AMX0318.

## Competitive Advantages
- Focus on high unmet needs with a rigorous, science-driven approach to drug development.
- Strong pipeline diversification across multiple rare and neurodegenerative diseases.
- Experienced team with collective expertise from therapeutic development through commercialization.
- Deep engagement with patient communities and care providers to understand unmet needs.
- Agile, hybrid-remote work environment that attracts and retains top talent.

## Strategic Focus
- Advancing late-stage clinical trials (avexitide Phase 3, AMX0035 Phase 2 in Wolfram syndrome).
- Expanding pipeline through business development and collaborations (e.g., Gubra).
- Leveraging regulatory designations (Breakthrough Therapy, Fast Track, Orphan Drug) to accelerate development.
- Continuing to build a culture of urgency, accountability, and innovation to serve patients with high unmet needs.

## Why Work Here
- **Culture**: Values-driven environment emphasizing accountability, audacity, authenticity, curiosity, and engagement. Rooted in connection with colleagues and the communities served.
- **Work Model**: Hybrid-remote with headquarters in Cambridge, MA. Three annual Anchor Weeks in-person and bi-weekly Amylyx Exchange meetings for connection.
- **Benefits**: Flexible PTO, 5% 401(k) employer contribution, paid parental leave, medical/dental/vision, HSA/FSA, employee assistance program, mobile reimbursement, learning and development program, recognition platform.
- **Engineering/Research Culture**: Emphasis on rigorous science, continuous learning, and generous knowledge sharing. Opportunities to work on cutting-edge therapies from preclinical through commercialization.

## Sources
1. [Amylyx Pharmaceuticals - Our Company](https://www.amylyx.com/our-company)
2. [Amylyx Pharmaceuticals - Careers](https://www.amylyx.com/careers)
3. [Amylyx Pharmaceuticals - Homepage](https://www.amylyx.com/)
4. [Jobs at Amylyx Pharmaceuticals - Greenhouse](https://job-boards.greenhouse.io/amylyx)
5. [Open Positions - Amylyx Pharmaceuticals](https://www.amylyx.com/open-positions)

## Other roles at Amylyx Pharmaceuticals

- [Associate Director, CMC, Program Management](https://feeny.ai/job/associate-director-cmc-program-management-amylyx-pharmaceuticals-cambridge-pnetd3rt746e) — Cambridge, MA
- [Vice President, Legal Operations](https://feeny.ai/job/vice-president-legal-operations-amylyx-pharmaceuticals-cambridge-71b8vbc15dep) — Cambridge, MA
- [Associate Director, MLR Governance](https://feeny.ai/job/associate-director-mlr-governance-amylyx-pharmaceuticals-cambridge-xh24z76102bd) — Cambridge, MA
- [Manager, IT Commercial and Medical Affairs Applications](https://feeny.ai/job/manager-it-commercial-and-medical-affairs-applications-amylyx-pharmaceuticals-nyy1y7pzys2v) — Cambridge, MA
- [Associate Director, Payroll and Equity](https://feeny.ai/job/associate-director-payroll-and-equity-amylyx-pharmaceuticals-cambridge-4y7b6kxbwdv7) — Cambridge, MA
- [Senior Director, Clinical Pharmacology](https://feeny.ai/job/senior-director-clinical-pharmacology-amylyx-pharmaceuticals-cambridge-r3xgzc2vtm4c) — Cambridge, MA
- [Director, FP&A - Commercial](https://feeny.ai/job/director-fp-a-commercial-amylyx-pharmaceuticals-cambridge-3rksjq438wrj) — Cambridge, MA
- [Accounts Payable Specialist](https://feeny.ai/job/accounts-payable-specialist-amylyx-pharmaceuticals-cambridge-qssg5jsxwh30) — Cambridge, MA
- [Manager, IT Infrastructure & Operations](https://feeny.ai/job/manager-it-infrastructure-operations-amylyx-pharmaceuticals-cambridge-zm42q1bgc603) — Cambridge, MA
- [Associate Director, Media Strategy & Execution](https://feeny.ai/job/associate-director-media-strategy-execution-amylyx-pharmaceuticals-cambridge-nxgvn4vm5h77) — Cambridge, MA